[5,10,15,20-Tetrakis(4-methoxyphenyl)porphyrinato]cobalt(II)>96.0%(T)5g

Benzoic acid, 4-[[(4-cyclohexylphenyl)methyl][2-[methyl[(2,3,4,5,6-pentafluorophenyl)sulfonyl]amino]acetyl]amino]-, 100mg

2,4-DIMETHYLBENZO[H]QUINOLIN-10-OL, 95.0%, 250mg

Pointes de pipettes 1-50 μl, Standard, Unité de recharge (palettisée), Non stérile, 960 Pièces

Ethyl 4-(4-bromophenyl)butanoate, 95.0%, 1g

(R)-2-([2,2'-Bipyridin]-6-yl)-4-isopropyl-4,5-dihydrooxazole, 97%, 100mg

3-Bromo-5-(methoxymethyl)benzaldehyde, 98%, 500mg

4-Chloro-3-fluoro-4'-hydroxybiphenyl, 97.0%, 250mg

3-bromo-2-methylpyrazolo[1,5-a]pyrimidine, 95.0%, 250mg

4-(4-(4-Methylpiperazin-1-yl)piperidin-1-yl)aniline, 95.0%, 5g

2-Amino-3-(4-(tert-butyl)phenyl)propanoic acid, 95.0%, 1g

(5-Bromo-3-methoxypyridin-2-yl)methanol, 96%, 1g

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-3-(4-(tert-butoxy)phenyl)propanoic acid, 97%, 250mg